Both preclinical and clinical studies in retinal vascular diseases such as diabetic eye disease, RVO and ROP have provided support and understanding for the contributory role of inflammation mediated by VEGFR1/PlGF/VEGF-A. Here, VEGFA is linked to diabetic eye disease.